Comparison of conventional diffusion-weighted imaging and intravoxel incoherent motion in differentiating between chromophobe renal cell carcinoma and renal oncocytoma: a preliminary study
British Journal of Radiology · 2024
DOI: 10.1093/bjr/tqae088 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift British Journal of Radiology, 2024. Verfasst von Qingqiang Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou 225001, China. Hauptthemen laut MEDLINE: Kidney Neoplasms, Carcinoma, Renal Cell, Adenoma, Oxyphilic, Diffusion Magnetic Resonance Imaging. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Yangzhou Social Development Fundation.
Abstract (Originalsprache)
Objective
Quantitative comparison of the diagnostic efficacy of conventional diffusion-weighted imaging (DWI) and intravoxel incoherent motion (IVIM) in differentiating between chromophobe renal cell carcinoma (ChRCC) from renal oncocytoma (RO).
Methods
A total of 48 patients with renal tumours who had undergone DWI and IVIM were divided into two groups—ChRCC (n = 28) and RO (n = 20) groups, and the apparent diffusion coefficient (ADC), true diffusivity (D), pseudo-diffusion coefficient (D*), perfusion fraction (f) and their diagnostic efficacy were compared between the two groups.
Results
The D* values were higher in the ChRCCs group compared to the RO groups (0.019 ± 0.003 mm2/s vs 0.008 ± 0.002 mm2/s, P < .05). Moreover, the ADC, D and f values were higher in ROs compared to ChRCCs (0.61 ± 0.08 × 10−3 mm2/s vs 0.51 ± 0.06 × 10−3 mm2/s, 1.02 ± 0.15 × 10−3 mm2/s vs 0.86 ± 0.07 × 10−3 mm2/s, 0.41 ± 0.05 vs 0.28 ± 0.02, P < .05). The areas of the ADC, D, D* and f values under the ROC curves in differentiating ChRCCs from ROs were 0.713, 0.839, 0.856 and 0.906, respectively. The cut-off values of ADC, D, D* and f were 0.54, 0.91, 0.013 and 0.31, respectively. The AUC, sensitivity, specificity and accuracy of the f values were 0.906, 89.3%, 80.0% and 89.6%, respectively. For pairwise comparisons of ROC curves and diagnostic efficacy, IVIM parameters, that is, D, D* and f offered better diagnostic accuracy than ADC in differentiating ChRCCs from ROs (P = .013, .016, and .008) with f having the highest diagnostic accuracy.
Conclusion
IVIM parameters presented better performance than ADC in differentiating ChRCCs from ROs. Advances in knowledge (1) D* values of ChRCCs were higher, while ADC, D and f values were lower than those of RO tumours. (2) f values had the highest diagnostic efficacy in differentiating ChRCC from RO. (3) IVIM parameters, that is, D, D* and f offered better diagnostic accuracy than ADC in differentiating ChRCC from RO (P=.013, .016, and .008).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou 225001, China.
ORCID-Profile: Qingqiang Zhu, Jing Ye
Förderung
- Yangzhou Social Development Fundation
Zitieren
APA
Zhu, Q., Sun, J., Ye, J., Zhu, W., & Chen, W. (2024). Comparison of conventional diffusion-weighted imaging and intravoxel incoherent motion in differentiating between chromophobe renal cell carcinoma and renal oncocytoma: a preliminary study. British Journal of Radiology. https://doi.org/10.1093/bjr/tqae088
Vancouver
Zhu Q, Sun J, Ye J, Zhu W, Chen W. Comparison of conventional diffusion-weighted imaging and intravoxel incoherent motion in differentiating between chromophobe renal cell carcinoma and renal oncocytoma: a preliminary study. British Journal of Radiology. 2024. doi:10.1093/bjr/tqae088
BibTeX
@article{Zhu2024,
author = {Zhu, Qingqiang and Sun, Jun and Ye, Jing and Zhu, Wenrong and Chen, Wenxin},
title = {Comparison of conventional diffusion-weighted imaging and intravoxel incoherent motion in differentiating between chromophobe renal cell carcinoma and renal oncocytoma: a preliminary study},
journal = {British Journal of Radiology},
year = {2024},
doi = {10.1093/bjr/tqae088}
}
EUVIMED